DexCom EBITDA Margin 2010-2024 | DXCM
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for DexCom (DXCM) over the last 10 years. The current EBITDA margin for DexCom as of June 30, 2024 is .
| DexCom EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-06-30 | $3.94B | $0.89B | 22.54% |
| 2024-03-31 | $3.80B | $0.85B | 22.33% |
| 2023-12-31 | $3.62B | $0.78B | 21.64% |
| 2023-09-30 | $3.40B | $0.68B | 19.89% |
| 2023-06-30 | $3.20B | $0.61B | 19.07% |
| 2023-03-31 | $3.02B | $0.56B | 18.49% |
| 2022-12-31 | $2.91B | $0.55B | 18.83% |
| 2022-09-30 | $2.79B | $0.42B | 15.00% |
| 2022-06-30 | $2.67B | $0.38B | 14.07% |
| 2022-03-31 | $2.57B | $0.38B | 14.77% |
| 2021-12-31 | $2.45B | $0.37B | 15.07% |
| 2021-09-30 | $2.32B | $0.46B | 19.84% |
| 2021-06-30 | $2.17B | $0.43B | 19.77% |
| 2021-03-31 | $2.03B | $0.39B | 19.09% |
| 2020-12-31 | $1.93B | $0.37B | 19.05% |
| 2020-09-30 | $1.82B | $0.36B | 19.71% |
| 2020-06-30 | $1.72B | $0.32B | 18.36% |
| 2020-03-31 | $1.60B | $0.24B | 15.19% |
| 2019-12-31 | $1.48B | $0.19B | 12.94% |
| 2019-09-30 | $1.35B | $-0.08B | -6.00% |
| 2019-06-30 | $1.22B | $-0.13B | -10.47% |
| 2019-03-31 | $1.13B | $-0.14B | -12.13% |
| 2018-12-31 | $1.03B | $-0.16B | -15.21% |
| 2018-09-30 | $0.92B | $0.02B | 1.64% |
| 2018-06-30 | $0.83B | $-0.00B | -0.36% |
| 2018-03-31 | $0.76B | $-0.02B | -1.97% |
| 2017-12-31 | $0.72B | $-0.03B | -3.76% |
| 2017-09-30 | $0.67B | $-0.05B | -6.88% |
| 2017-06-30 | $0.63B | $-0.06B | -10.11% |
| 2017-03-31 | $0.60B | $-0.07B | -11.69% |
| 2016-12-31 | $0.57B | $-0.05B | -8.55% |
| 2016-09-30 | $0.53B | $-0.04B | -7.88% |
| 2016-06-30 | $0.49B | $-0.07B | -13.91% |
| 2016-03-31 | $0.45B | $-0.05B | -11.91% |
| 2015-12-31 | $0.40B | $-0.05B | -11.69% |
| 2015-09-30 | $0.36B | $-0.05B | -13.24% |
| 2015-06-30 | $0.32B | $-0.01B | -3.13% |
| 2015-03-31 | $0.29B | $-0.01B | -4.56% |
| 2014-12-31 | $0.26B | $-0.01B | -5.02% |
| 2014-09-30 | $0.23B | $-0.02B | -7.49% |
| 2014-06-30 | $0.20B | $-0.02B | -8.96% |
| 2014-03-31 | $0.18B | $-0.02B | -12.36% |
| 2013-12-31 | $0.16B | $-0.02B | -13.04% |
| 2013-09-30 | $0.14B | $-0.03B | -19.01% |
| 2013-06-30 | $0.12B | $-0.04B | -31.15% |
| 2013-03-31 | $0.11B | $-0.04B | -39.45% |
| 2012-12-31 | $0.10B | $-0.05B | -48.48% |
| 2012-09-30 | $0.09B | $-0.05B | -60.23% |
| 2012-06-30 | $0.08B | $-0.05B | -60.24% |
| 2012-03-31 | $0.08B | $-0.04B | -53.09% |
| 2011-12-31 | $0.08B | $-0.04B | -53.33% |
| 2011-09-30 | $0.07B | $-0.04B | -55.07% |
| 2011-06-30 | $0.06B | $-0.04B | -60.32% |
| 2011-03-31 | $0.05B | $-0.04B | -77.78% |
| 2010-12-31 | $0.05B | $-0.04B | -82.00% |
| 2010-09-30 | $0.04B | $-0.04B | -93.18% |
| 2010-06-30 | $0.04B | $-0.04B | -102.56% |
| 2010-03-31 | $0.03B | $-0.04B | -123.53% |
| 2009-12-31 | $0.03B | $-0.04B | -144.83% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $27.786B | $3.622B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $234.954B | 28.16 |
| Intuitive Surgical (ISRG) | United States | $175.058B | 99.12 |
| Alcon (ALC) | Switzerland | $48.180B | 33.92 |
| IQVIA Holdings (IQV) | United States | $45.858B | 25.99 |
| Edwards Lifesciences (EW) | United States | $42.144B | 27.01 |
| IDEXX Laboratories (IDXX) | United States | $39.616B | 47.66 |
| STERIS (STE) | Ireland | $23.777B | 27.74 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.808B | 0.00 |
| Waters (WAT) | United States | $20.560B | 30.65 |
| Hologic (HOLX) | United States | $18.870B | 20.52 |
| Sysmex ADR (SSMXY) | Japan | $12.134B | 38.05 |
| Teleflex (TFX) | United States | $11.552B | 17.96 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.379B | 12.76 |
| Globus Medical (GMED) | United States | $9.844B | 27.54 |
| Penumbra (PEN) | United States | $7.859B | 81.58 |
| Glaukos (GKOS) | United States | $7.357B | 0.00 |
| Masimo (MASI) | United States | $6.252B | 33.48 |
| TransMedics (TMDX) | United States | $5.606B | 240.09 |
| Integer Holdings (ITGR) | United States | $4.361B | 25.50 |
| PROCEPT BioRobotics (PRCT) | United States | $4.103B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.848B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.736B | 16.05 |
| Elekta AB (EKTAY) | Sweden | $2.601B | 21.19 |
| Inari Medical (NARI) | United States | $2.519B | 0.00 |
| Veracyte (VCYT) | United States | $2.423B | 150.24 |
| Nihon Kohden (NHNKY) | Japan | $2.287B | 14.23 |
| RxSight (RXST) | United States | $2.086B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.578B | 7.19 |
| OPKO Health (OPK) | United States | $1.172B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.142B | 0.00 |
| Artivion (AORT) | United States | $1.137B | 104.38 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.113B | 19.85 |
| Silk Road Medical (SILK) | United States | $1.102B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.969B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.774B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.723B | 18.26 |
| Paragon 28 (FNA) | United States | $0.695B | 0.00 |
| SiBone (SIBN) | United States | $0.693B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.666B | 0.00 |
| IRadimed (IRMD) | United States | $0.595B | 32.16 |
| AxoGen (AXGN) | United States | $0.576B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.384B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.373B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.358B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.341B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.325B | 9.92 |
| Delcath Systems (DCTH) | United States | $0.306B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.300B | 0.00 |
| Inogen (INGN) | United States | $0.291B | 0.00 |
| NeuroPace (NPCE) | United States | $0.231B | 0.00 |
| Nevro (NVRO) | United States | $0.231B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| CVRx (CVRX) | United States | $0.215B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.187B | 13.09 |
| Atossa Genetics (ATOS) | United States | $0.172B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.141B | 0.00 |
| 908 Devices (MASS) | United States | $0.137B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.134B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 15.90 |
| Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Envoy Medical (COCH) | United States | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.056B | 0.00 |
| LENSAR (LNSR) | United States | $0.054B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.043B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.037B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| ReWalk Robotics (LFWD) | United States | $0.030B | 0.00 |
| Neuronetics (STIM) | United States | $0.027B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.017B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.015B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |